(Q38103631)

28 August 2017

title

Autoimmune hepatitis in diverse ethnic populations and geographical regions (English)

1 reference

28 August 2017

1 reference

Albert J Czaja

1

1 reference

28 August 2017

language of work or name

1 reference

1 May 2013

1 reference

Expert Review of Gastroenterology & Hepatology

28 August 2017

published in

1 reference

28 August 2017

volume

7

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

365-385

1 reference

ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY

28 August 2017

cites work

1 reference

Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

21 January 2018

1 reference

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

21 January 2018

1 reference

Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis

21 January 2018

1 reference

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

21 January 2018

1 reference

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

21 January 2018

1 reference

HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis

21 January 2018

1 reference

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

21 January 2018

1 reference

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

Chronic Liver Disease: Differences in Autoimmune Serological Reactions between Australians and Asians

21 January 2018

1 reference

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

Autoimmune hepatitis in African Americans: presenting features and response to therapy

21 January 2018

1 reference

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin

21 January 2018

1 reference

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

21 January 2018

1 reference

Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

21 January 2018

1 reference

Autoimmune hepatitis in special patient populations

21 January 2018

1 reference

Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition

21 January 2018

1 reference

Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis

21 January 2018

1 reference

Racial disparity in liver disease: Biological, cultural, or socioeconomic factors

21 January 2018

1 reference

Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.

21 January 2018

1 reference

Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients.

21 January 2018

1 reference

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis.

21 January 2018

1 reference

The impact of ethnicity on the natural history of autoimmune hepatitis

21 January 2018

1 reference

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

Rapidity of treatment response and outcome in type 1 autoimmune hepatitis

21 January 2018

1 reference

Structural determinants of P-glycoprotein-mediated transport of glucocorticoids

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

21 January 2018

1 reference

Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers

21 January 2018

1 reference

Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

Drug choices in autoimmune hepatitis: part A--Steroids

21 January 2018

1 reference

Drug choices in autoimmune hepatitis: part B--Nonsteroids

21 January 2018

1 reference

Liver transplantation trends for older recipients: regional and ethnic variations

21 January 2018

1 reference

Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study

21 January 2018

1 reference

Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States

21 January 2018

1 reference

Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma

21 January 2018

1 reference

Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.

21 January 2018

1 reference

Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma

21 January 2018

1 reference

Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.

21 January 2018

1 reference

Are there ethnicity-based differences in the evaluation of individuals with abnormal liver biochemistries?

21 January 2018

1 reference

Survival after liver transplantation: Is racial disparity inevitable?

21 January 2018

1 reference

Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B

21 January 2018

1 reference

Hepatocellular carcinoma survival in uninsured and underinsured patients.

21 January 2018

1 reference

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis.

21 January 2018

1 reference

Chronic liver disease in the Hispanic population of the United States

21 January 2018

1 reference

Chronic liver disease mortality in the United States, 1990-1998.

21 January 2018

1 reference

MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis

21 January 2018

1 reference

Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States

21 January 2018

1 reference

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

21 January 2018

1 reference

Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type

21 January 2018

1 reference

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

21 January 2018

1 reference

Chronic liver disease in Aboriginal North Americans

21 January 2018

1 reference

The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the Americas

21 January 2018

1 reference

Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis

21 January 2018

1 reference

HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection

21 January 2018

1 reference

Autoimmune hepatitis. Part A: pathogenesis

21 January 2018

1 reference

Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features

21 January 2018

1 reference

Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience

21 January 2018

1 reference

Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.

21 January 2018

1 reference

Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.

21 January 2018

1 reference

Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis

21 January 2018

1 reference

Long-term outcome of liver transplantation for autoimmune hepatitis

21 January 2018

1 reference

Liver transplantation due to fulminant hepatic failure.

21 January 2018

1 reference

Liver transplantation for autoimmune hepatitis: fulminant versus chronic hepatitis presentation.

21 January 2018

1 reference

A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence

21 January 2018

1 reference

Autoimmune hepatitis in childhood: a 20-year experience.

21 January 2018

1 reference

Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

21 January 2018

1 reference

Autoimmune hepatitis in children: what is different from adult AIH?

21 January 2018

1 reference

Unique features of primary sclerosing cholangitis in children

21 January 2018

1 reference

Autoimmune liver diseases in children - what is different from adulthood?

21 January 2018

1 reference

Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.

21 January 2018

1 reference

An unusual form of autoimmune hepatitis in young Somalian men.

21 January 2018

1 reference

Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients

21 January 2018

1 reference

Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

21 January 2018

1 reference

Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.

21 January 2018

1 reference

Clinico-laboratory study on children with auto-immune hepatitis in Upper Egypt

21 January 2018

1 reference

Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia

21 January 2018

1 reference

Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

21 January 2018

1 reference

Type 1 autoimmune hepatitis in Turkish patients: absence of association with HLA B8.

21 January 2018

1 reference

Autoantibody-negative autoimmune hepatitis

21 January 2018

1 reference

Our experience with fulminant hepatic failure in Turkish children: etiology and outcome

21 January 2018

1 reference

Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.

21 January 2018

1 reference

Celiac disease in children and adolescents with autoimmune hepatitis: a single-centre experience.

21 January 2018

1 reference

Autoimmune hepatitis in the Indian subcontinent: 7 years experience

21 January 2018

1 reference

Spectrum of autoimmune liver diseases in western India.

21 January 2018

1 reference

Autoimmune hepatitis in India: profile of an uncommon disease

21 January 2018

1 reference

Non-organ-specific autoantibodies in Indian patients with chronic liver disease

21 January 2018

1 reference

The clinical spectrum of chronic liver disease in children presenting to a tertiary level teaching hospital in New Delhi

21 January 2018

1 reference

Acute and acute severe (fulminant) autoimmune hepatitis

21 January 2018

1 reference

Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis

21 January 2018

1 reference

Predictors of outcome in acute-on-chronic liver failure in children.

21 January 2018

1 reference

Acute on chronic liver disease in children from the developing world: recognition and prognosis

21 January 2018

1 reference

Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India.

21 January 2018

1 reference

Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

Fulminant hepatitis and late onset hepatic failure in Japan.

21 January 2018

1 reference

Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis

21 January 2018

1 reference

Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center

21 January 2018

1 reference

Changing etiologies and outcomes of acute liver failure: A perspective from Japan

21 January 2018

1 reference

Autoimmune fulminant liver failure in adults: Experience in a Japanese center

21 January 2018

1 reference

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Clinical features of Japanese male patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis

21 January 2018

1 reference

Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

21 January 2018

1 reference

Long-term outcome of Japanese patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Efficacy and safety of prednisolone in patients with autoimmune hepatitis

21 January 2018

1 reference

Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan.

21 January 2018

1 reference

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

21 January 2018

1 reference

Current trends in the diagnosis and treatment of autoimmune hepatitis in Japan

21 January 2018

1 reference

Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey

21 January 2018

1 reference

Living-donor liver transplantation for autoimmune hepatitis and autoimmune hepatitis-primary biliary cirrhosis overlap syndrome

21 January 2018

1 reference

Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients.

21 January 2018

1 reference

Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese

21 January 2018

1 reference

Genetic background of autoimmune hepatitis in Japan.

21 January 2018

1 reference

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients

21 January 2018

1 reference

A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis

21 January 2018

1 reference

Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Fas polymorphisms influence susceptibility to autoimmune hepatitis.

21 January 2018

1 reference

Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese

21 January 2018

1 reference

Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

Genetic bases of autoimmune hepatitis.

21 January 2018

1 reference

Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis

21 January 2018

1 reference

Advances in the current treatment of autoimmune hepatitis

21 January 2018

1 reference

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

21 January 2018

1 reference

Long-term prognosis in patients with severe late radiation enteropathy: a prospective cohort study

21 January 2018

1 reference

Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease

21 January 2018

1 reference

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

21 January 2018

1 reference

Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.

21 January 2018

1 reference

Autoimmune hepatitis with acute presentation in Japan

21 January 2018

1 reference

Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

Effect of race on outcome of orthotopic liver transplantation: a cohort study

21 January 2018

1 reference

Orthotopic liver transplantation for autoimmune hepatitis and cryptogenic chronic hepatitis in children

21 January 2018

1 reference

HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

Liver Transplantation at a University Hospital, Faculty of the Medicine of Ribeirão Preto, University of São Paulo: Results for the First 60 Recipients

21 January 2018

1 reference

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

21 January 2018

1 reference

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus

21 January 2018

1 reference

Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.13.21

1 reference

28 August 2017

1 reference